Biographical
Summary | Patents | Awards
and Honors |
Endowed/Honorary Lectureships | Career
Achievements
Editorial Boards |
Professional Societies and Positions Held |
Extracurricular Activities
Biographical Summary
Nicholas A. Peppas
is the Fletcher Pratt Chaired Professor of
Chemical Engineering, Biomedical Engineering and
Pharmacy at the University of Texas at Austin.
He is a world leader in biomaterials, controlled drug
delivery, biomaterials and bionanotechnology. He
received a Dipl. Eng. from NTU Athens (1971) and a Sc.
D. from MIT (1973).
Dr Peppas has published more than 1,025 refereed
publications, 350 proceedings and 320 abstracts, and is
the inventor of 35 US and international patents. He is
the coauthor or coeditor of 31 books and volumes,
including the classic, three-volume Hydrogels in
Medicine and Pharmacy (CRC Press, 1987), a standard
reference in the field of biomaterials with more than
3,000 citations, the monograph Pulsatile Drug
Delivery, (WSGS, Stuttgart, 1993), two books on
Biopolymers (Springer, 1994), the monograph
Physicochemical and Cellular Foundations of Biomaterials
Science (Academic Press, 2004), the book
Intelligent Therapeutics: Biomimetic Systems and
Nanotechnology in Drug Delivery (Elsevier, 2004) and
his new monograph Nanotechnology in Therapeutics
(Horizon Press, 2007).
His pioneering
contributions have received more than 28,000 citations
making him one of the most cited chemical or biological
scientists in the world and one of the three most cited
biomedical engineers. Of particular note is his
lifetime effort to rationalize the design and
development of biomaterials, drug delivery systems and
medical devices. This has led to the development of the
mathematical and physicochemical foundations of these
fields including several theories and equations, widely
used now in biomedical engineering. These include the
Peppas equation (for the analysis of the abnormal and
highly non-Fickian release and delivery of drugs,
peptides and proteins from controlled release devices),
the Peppas-Merrill equation (for the analysis of protein
transport through biomedical membranes), the
Brannon-Peppas theory (the first theory to analyze the
behavior of intelligent, ionic gels in multicomponent
biological fluids), the Huang-Peppas interpenetration
theory of tethered structures across biological tissues,
and the Peppas-Ritger correlation which has more than
1,000 citations in the last 15 years. His modeling,
biomaterials, cellular and drug delivery research has
been funded continuously since 1980 by NIH and since
1978 by NSF.
Dr. Peppas’ patents have been
licensed or sublicensed to a number of pharmaceutical,
chemical, biotechnology and medical device companies. A
number of these companies were launched on the basis of
these patent licenses. He served in numerous US
government panels of NSF, NIH and other Federal
Agencies. Among others he served in the
Nanotechnology Technical
Advisory Board to the President's Council of Advisors on
Science and Technology from 2003-06. In addition he has
served as a member of the Advisory Boards of eleven
companies and as a consultant of more than 60 companies,
law firms and brokerage firms.
He has been recognized by more than 120
international awards. These include the highest research
recognitions from the American Institute of
Chemical Engineers (the 2006 William H. Walker
Award, the 2006 Jay Bailey Biological Engineering Award,
and the 2007 Institute Lecture, along with the 1994
Food, Pharmaceuticals and Bioengineering Award, the 1984
CME Stine Materials Engineering and Sciences Award, and
the 1994 Best Paper Award of the AIChE Meeting), the
highest research recognitions from the Society for
Biomaterials (the 2005 Founders Award for life
time contributions, and the 1992 Clemson Award for Basic
Research), the highest recognitions of the
American Association of Pharmaceutical Scientists
(the 2002 Dale E. Wurster Award in Pharmaceutics, and
the 1999 Research Achievement Award in Pharmaceutical
Technology), the highest scientific recognitions of the
Controlled Release Society (the 1991
Founders Award, the 2002 Eurand Award for Outstanding
Contributions in Oral Drug Delivery, the 1999 J. Heller
Award, and the 2003 Capsugel Award), the 1998 and 2003
Materials Research Society Best Paper
Awards, the 1997 Whitaker Award from the
International Society for Artificial Organs, the
2002 Newsmaker of the Year Award of the American
Chemical Society, the 2002 Pioneer in Biomedical
Engineering Award and the 1996 Whitaker Award from the
IEEE Engineering in Medicine and Biology Society,
and the 1995 APV Medal for Distinguished Pharmaceutical
Contributions from the International
Pharmaceutical Association. He has received the
highest scientific recognitions from both Universities
with which he has been associated (the 2007 Research
Excellence Career Award and the 2004 Hamilton Best Paper
Award from the University of Texas at Austin;
and the 2002 Sigma Xi Award for Best Research and the
2000 Herbert McCoy Research Award from Purdue
University)
In 2006 Dr. Peppas was elected a member of the
National Academy of Engineering, and the
Academy of Medicine,
Engineering and Science of Texas,
and in 2005 a member of the Académie Nationale de
Pharmacie (France). He is one of only two US
chemical engineers to have been elected in this
academy. An international ambassador of chemical and
biomedical engineering, he has received honorary
doctorates from the Universities of Ghent
(Belgium), Parma (Italy), and Athens (Greece). In
addition, he has been a Visiting Professor
at the Universities of Geneva, Paris-Sud (Orsay), Parma,
Pavia, Naples, Berlin (Free University), Santiago de
Compostela, Complutense (Madrid), Hoshi (Tokyo),
Hacettepe (Ankara), Athens, Hebrew (Jerusalem), Nanyang
(Singapore) and California Institute of Technology.
Dr. Peppas is the Chair of the College of Fellows of the
American Institute of Medical and Biological
Engineers (AIMBE), a Past-President of the
Society for Biomaterials (2002-2003), a
Past-President of the Controlled Release Society
(1987-1988), and a past Director of the American
Institute of Chemical Engineers (AIChE,
2000-2002). He was elected an inaugural Fellow
of the Biomedical Engineering Society, a founding Fellow
of AIMBE, a Fellow of the American Institute of Chemical
Engineers, the American Physical Society, the Society
for Biomaterials, the American Association of
Pharmaceutical Scientists, and the American Association
for the Advancement of Science, and an Honorary Member
of the Italian Society for Natural Sciences and
Medicine.
Peppas is also a recognized teacher and educator. He has
supervised the theses of more than 130 graduate students
and visiting scientists including 73 PhDs, of which 33
are now professors in other Universities. He has also
nurtured more than 470 undergraduates who have worked in
his laboratory. Many of them have become leading
biomedical scientists, engineers, physicians and medical
professionals. For this reason, the American
Association of Engineering Education has
recognized him with all its major awards including the
2000 General Electric Senior Research Award recognizing
the best engineering researcher of the USA, the 1992
George Westinghouse Award recognizing the best teacher,
the 1988 Curtis McGraw Award for best engineering
research under the age of 40, and the 2006 Dow Chemical
Engineering award. He has also received numerous
counselor and teaching awards, the latest being the 2007
Most Outstanding ChE Faculty
Member Award.
He serves as a consulting editor of
Pharmaceutical Research (2005- ), as the editor of
the Elsevier Biomaterials Monograph Series and as
an Associate Editor of the Cambridge
University Press Biomedical Engineering Monograph
Series. He has served as the editor of Advances
in Chemical Engineering (1998-2003), Biomaterials
(1982-2001), European Journal of Pharmaceutics and
Biopharmaceutics (1992-1995) and Elsevier
Chemical Engineering Book Series (1985-1990). He
sits on the editorial boards of numerous other journals.
Additional biographical
information
Professor
Nicholas A. Peppas is an active researcher in the fields
of bionanotechnology, remote sensing, molecular
recognition processes, controlled drug delivery,
biomedical engineering, biomaterials, molecular modeling
of protein structures in contact with biomaterials and
tissues, and modeling of biomedical devices. Peppas is
in charge of the Laboratory for Biomaterials, Drug
Delivery, Bionanotechnology, and Molecular Recognition
with 20 researchers (doctoral students, visiting
scientists, technicians) and an annual budget of $2M.
Peppas was
educated in chemical engineering at the National
Technical University of Athens, Greece (Dipl.Eng., 1971)
and at the Massachusetts Institute of Technology (Sc.D.,
1973) and did postdoctoral work at the Arteriosclerosis
Center of MIT. He joined Purdue University as an
Assistant Professor of Chemical Engineering in 1976, and
was promoted to Associate Professor in 1978 and
Professor in 1982. From 1993 to 2002 he was the
Showalter Distinguished Professor of Chemical and
Biomedical Engineering at Purdue University in
recognition of his research contributions to the fields
of biomaterials, drug delivery, pharmaceutical
technology, and biomedical engineering.
For these
contributions, he received honorary doctorates from the
University of Ghent, Belgium and the University of
Parma, Italy, both in 1999, and from the University of
Athens, Greece in 2000.
In
addition to his main academic appointment, Professor
Peppas has been active in international collaboration
with major research centers around the world. He has
served as a Visiting Professor at the University of
Geneva, Switzerland (Fall 1982), the California
Institute of Technology (Spring 1983), the University of
Paris (Fall 1986), the Hacettepe University of Ankara,
Turkey (November 1986), the University of Pavia, Italy
(May 1988), the University of Parma, Italy (Fall 1987
and Spring 1993), the Hoshi University of Tokyo, Japan
(Springs 1994, 1995 and 1997), the Hebrew University of
Jerusalem, Israel (Spring 1994), the University of
Naples, Italy (May 1996), the University of Athens,
Greece (Spring 2000), the Free University of Berlin,
Germany (Spring 2001), the University of Santiago de
Compostela, the Complutense University of Madrid, Spain
(Spring 2001), and the Nanyang University of Singapore
(May 2005).
Peppas’
administrative experience and contributions have been
numerous and far-reaching. At UT Austin he serves as
Director of the Laboratory for Biomaterials, Drug
Delivery, Bionanotechnology, and Molecular Recognition.
Since 2003 he has been also the Director of the NSF
Program on Cellular and Molecular Imaging for
Diagnostics and Therapeutics.
At Purdue
he was the motive force behind the development of the
Biomedical Engineering Program at Purdue (1995), and was
successful in getting major Whitaker, NSF and NIH grants
for the University. These grants helped in the
establishment of the Department of Biomedical
Engineering. Peppas was also instrumental in
establishing a unique cross-disciplinary program in the
broader field of Biomedical and Pharmaceutical
Engineering, and Nanotechnology. In 1999 he founded and
became the first Director (1999-2002) of the NSF Program
on Therapeutic and Diagnostic Devices of Purdue
University.
Peppas'
research contributions have been in several areas of
bionanotechnology, drug delivery, biomaterials,
biomolecular engineering, mass transfer, kinetics and
reaction engineering, polymer science and biomedical
engineering. The multidisciplinary approach of his
research in biomolecular engineering blends modern
molecular and cellular biology with engineering to
generate next-generation systems and devices, including
bioMEMS with enhanced applicability, reliability,
functionality, and longevity. The fundamental studies of
his group have provided valuable results on biomaterials
design and development. Physiologically-controlled and
disease-responsive, feedback control-based devices
require the operation/function of electrical and
mechanical parts as a result of on-line measurement of
physiological variables of the body, blood or other
biological fluids. Peppas utilized the basics of
biomedical transport phenomena, control theory, and
kinetic behavior to design novel devices and to optimize
their behavior in the body or in contact with the body.
Adjustment of appropriate components of these devices
was based on simple or sophisticated control or other
physiological based models. Peppas and his group are in
a unique position to be able to provide prototypes for
direct medical testing. To that end, they have
investigated the biocompatibility of all components of
these devices and have provided knowledge of cellular
response mechanisms that may be related to changes in
immunological status, physical tissue damage. Research
in physiologically-responsive devices has sought to show
how it is possible to use classical and biomedical
engineering principles, mathematics, transport phenomena
and control theory to design devices and artificial
organs, often based on "intelligent materials," which
are responsive to changes in the surrounding
environment. Peppas developed feedback control devices,
such as glucose-sensitive microsensors that can respond
to abnormal glucose levels by releasing incorporated
insulin to the blood at desired rates. Such feedback
control systems could be perfected for use in treatment
of diabetes. In addition, he developed
temperature-sensitive devices which can be used for
treatment of malaria by release of antipyretics, etc.
Peppas is
internationally known for his work on the preparation,
characterization and evaluation of the behavior of
compatible, crosslinked polymers known as hydrogels,
which have been used as biocompatible materials and in
controlled release devices, especially in controlled
delivery of drugs, peptides and proteins, development of
novel biomaterials, biomedical transport phenomena, and
biointerfacial problems. Peppas’ polymer research has
examined fundamental aspects of the thermodynamics of
polymer networks in contact with penetrants, the
conformational changes of networks under load or in the
presence of a diluent, the anomalous transport of
penetrants in glassy polymers, and the kinetics of fast
UV-polymerization reactions. In the field of controlled
release, his group has provided the fundamental basis
for a rational development of such systems. In addition,
his work has led to a series of novel controlled release
systems known as swelling controlled release systems, a
series of pH-sensitive devices for drug delivery and a
wide range of bio- and mucoadhesive systems. Other
biomedical work of his group had dealt with
understanding of transport of biological compounds in
tissues, analysis of polymer/tissue interactions, and
understanding of the behavior of biomembranes.
His
research has led to the development of a number of
biomedical polymers and devices. For example, Peppas was
the first to develop the freezing-thawing technique for
preparation of novel poly(vinyl alcohol) gels in 1975.
This technique led to a number of novel biomedical
materials. His group pioneered the use of hydrogels in
drug delivery applications, including epidermal
bioadhesive systems and systems for the release of
theophylline, proxyphylline, diltiazem, and oxprenolol.
The first applications of this work were made public in
1979. Using intelligent polymers as early as 1984,
Peppas and his group were the first to use such
pH-sensitive and temperature-sensitive systems for
modulated release of streptokinase and other
fibrinolytic enzymes. His group has also developed novel
buccal and vaginal controlled release devices.
More
recently, his group has announced new inventions of oral
insulin delivery systems and new biomaterials. More
recently, his group has announced new inventions of oral
insulin delivery systems and new biomaterials. These
devices release insulin orally, “protecting” the insulin
throughout its transport in the stomach, upper small
intestine, and, eventually, blood, and bypassing
diabetics’ need for several daily injections. Peppas’
group has shown that these new systems exhibit very high
bioavailability. This is the first time that an oral
system has been shown to be effective for oral delivery
of proteins, especially insulin. In fact, the same
technology has been used for the transmucosal (oral,
buccal) delivery of calcitonin (for treatment of
osteoporosis in postmenopausal women) and
interferon-alpha (for cancer therapy). Finally, Peppas'
group has invented new materials for hard,
oxygen-permeable contact lenses, and for reconstruction
of vocal cords.
He has
been a member of numerous NSF, NIH and other federal
panels and has served on various committees that have
defined programmatic activities of the government. Among
other committees he is presently a member of the
Nanotechnology Technical Advisory Group of the
President's Council of Advisors on Science and
Technology.
Peppas is
the author of 1,025 publications, 320 abstracts and 35
US and international patents. He is the coauthor or
coeditor of 31 books and volumes, including the
three-volume Hydrogels in Medicine and Pharmacy (CRC
Press, 1987), the monograph Pulsatile Drug Delivery
(Stuttgart, 1993), two books on Biopolymers
(Springer, 1994) and the monograph Molecular and
Cellular Foundations of Biomaterials (Academic
Press, 2004). In addition, he has given more than 240
invited seminars and 880 scientific presentations in 32
countries.
Peppas is
one of the most cited scientists with more than 28,000
citations. In the ISI survey of most cited authors in
the world for the period 1981-1997, Peppas ranked first
in citations among all biomedical scientists.
He is a
consulting Editor of Pharmaceutical Research.
From 1998 to 2003 he was the editor of Advances in
Chemical Engineering. From 1982 to 2001 he was the
editor of the premier journal in his field,
Biomaterials. From 1985 to 1990 he was also the
editor of the Elsevier Chemical Engineering Book
Series. He sits on the editorial boards of numerous
other journals, including the Journal of Controlled
Release, Nanomedicine, International Journal of
Nanomedicine, Biomedical Nanodevices, Industrial
Engineering Chemistry Research, Journal of Applied
Polymer Science, Advanced Drug Delivery Reviews, Journal
of Biomedical Materials Research, Journal of
Biomaterials Science, Biomedical Materials, Tissue
Engineering, Journal of Drug Delivery and Technology,
and the European Journal of Pharmaceutics and
Biopharmaceutics (where he served as US Editor from
1992 to 1995).
He has
been active in various societies. Since 1975 he has been
active in the Society for Biomaterials and served as its
President (2003-04). Since 1981 he has been one of the
leaders of the 2800-member Controlled Release Society.
He guided it as its President in 1987-88, and organized
the 1985 (Geneva) and 1993 (Washington) meetings of the
Society as well as many other conferences and workshops.
From 1994 to 1998 he chaired the Global Networks
Committee of CRS, which was responsible for the
organization of active controlled release societies in
the United Kingdom, Germany, Italy, Spain/Portugal,
Greece, Israel, Thailand, Korea, China, Taiwan and
Argentina.
In
addition he has been very active in the American
Institute of Chemical Engineers, where he was a Director
(1999-2002), the 1988-90 Chairman of its 1500-member
Materials Division and a Director of the Food,
Pharmaceuticals and Bioengineering Division. He is also
a member of the American Physical Society, American
Chemical Society, New York Academy of Sciences,
Materials Research Society, American Association of
Pharmaceutical Scientists, Biomedical Engineering
Society, Tissue Engineering Society, North American
Membrane Society, American Society for Engineering
Education, American Association for the Advancement of
Sciences, Sigma Xi, and Phi Kappa Phi.
He has been recognized
by various awards including the 2007 Institute Lecture of
AIChE, the 2007 Carreer Research Excellence Award of the
University of Texas, the 2007 Most Outstanding ChE
Faculty Member by the Engineering Student Council of the
University of Texas, the 2006 Jay Bailey Award of the
Biological Engineering Society of AIChE, the 2006
William H. Walker Award of AIChE, the 2006 Best Paper
Award of the European Controlled Release Meeting, the
2006 Dow Chemical Engineering and Lctureship Award of
the American Society for Engineering Education, the 2005
Best Paper Award of the International Microencapsulation
Society, the 2005 Distinguished Scientist Award of the
Houston Society of Engineering in Medicine and Biology,
the 2005 Founders Award of the Society for Biomaterials,
the 2005 Whitaker Graduate Student Award of the Society
for Biomaterials, the 2004 Research Excellence Award for Best Research Paper of the University of
Texas, the 2003 Materials Research Society
Graduate Research Award, the 2003 Capsugel Award for
Best Graduate Student Research in Controlled Drug
Delivery, the 2003 Nagai Foundation Award for Research,
the
2002 Dale
E. Wurster Award in Pharmaceutics of the American
Association of Pharmaceutical Scientists, the 2002
Graduate Student Award for Outstanding Research of the
Biomedical Engineering Society, the 2002 Newsmaker of
the Year of the American Chemical Society, the 2002
Graduate Student Award of the IEEE Engineering in
Medicine and Biology Society, the 2002 Eurand Award for
Outstanding Contributions in Oral Drug Delivery of the
Controlled Release Society, the 2002 recognition as a
Pioneer in Biomedical Engineering from the IEEE
Engineering in Medicine and Biology Society, the 2002
Sigma Xi Award for Best Research at Purdue University,
the 2002 Chorafas Foundation Award for Best
Dissertation, the 2002 Best Graduate Student Paper Award
of the Materials Research Society, the 2000 General
Electric Senior Research Award of ASEE recognizing the
best engineering researcher of the USA, the 2000 Herbert
McCoy Award for exceptional research by Purdue
University, the 2000 APV Best Paper Award, the 2000 APV
Best thesis in the Pharmaceutical Sciences Award, 1999
Research Achievement Award in Pharmaceutical Technology
of AAPS, the 1995 APV-International Pharmaceutical
Technology Medal, the 1994 Pharmaceutical and
Bioengineering Award of AIChE, the 1992 Clemson Award
for Basic Research of the Society for Biomaterials, the
1992 George Westinghouse Award of ASEE, the 1991
Founders Award for Outstanding Research from the
Controlled Release Society, the 1988 Curtis McGraw Award
of ASEE for best engineering research under the age of
40, the 1984 Materials Engineering and Sciences Award of
AIChE. Also he and his students have received several
"best paper" awards including the 1999 AAPS Award, the
1998 Materials Research Society Award, the 1994 Best
Paper Award of the Annual AIChE Meeting.
He has
given numerous distinguished lectureships including the
Plenary Lectureships of
the National
Biotechnology Conference of AAPS (San Diego, 2007), the
9th Greek Scientific Chemical Engineering Conference
(Athens, 2007), the 31st Annual Meeting of the Society
for Biomaterials (Chicago, 2007), the Pharmaceutical
Sciences World Congress (Amsterdam, 2007), the Dow
Distinguished Lectureship, American Society for
Engineering Education (Chicago, 2006), the 3rd
World Congress on Biomimetics, Artificial Muscles &
Bionanotechnology (Lausanne, 2006), the European Polymer
Congress (Moscow, 2005), the Society for Biomaterials
Meeting (Memphis, 2005), the Third World Congress on
Drug Absorption, Transport and Delivery (Barcelona,
2005), the American Institute of Medical and Biological
Engineering (Washington, 2004), the European Materials
Research Society Meeting (Warsaw, 2004), the 20th
Japanese Drug Delivery Systems Meeting (Tokyo, 2004),
the Gattefossé Lecturer Meeting (Lyon, 2004), the NIH/NSF
Transport in Biological Systems Panel (Washington,
2004), the NIH/NSF Bionanotechnology Panel (Washington,
2003), the 4th Annual BioMEMS and NanoTech meeting
(Washington, 2003), the Gattefossé Lecture (St. Rémy,
2003), the Harry G. Fair Distinguished Lecture
(University of Oklahoma 2003), the Larson-Ruth
Distinguished Lecture (Iowa State University, 2003), the
Biomedical Engineering Society Meeting, (Houston, 2003),
the ACS Meeting (Boston, 2002),
the
International Pharmaceutical Technology Symposium
(Istanbul, 2002), the 29th International Symposium of
Controlled Release of Bioactive Agents (Seoul, 2002),
the Particles International Conference (Orlando, 2002),
the Third World Meeting on Pharmaceutics,
Biopharmaceutics and Pharmaceutical Technology,
(Florence, 2002), the 6th International Symposium on
Polymers for Advanced Technologies (Eilat, 2001), the
North American Membrane Society Meeting (Boulder, 2000),
the 6th World Congress of Biomaterials (Hawaii, 2000),
the Symposium on Biomedical Polymers for the 21st
Century (Boston, 2000), the Drug Delivery in the Third
Millennium Meeting (Pisa, 1999), Third Central European
Symposium on Pharmaceutical Technology (Portoroz, 1999),
American Institute of Chemical Engineers Meeting (Miami,
1998), International Pharmaceutical conference (1998),
Materials Research Society Meeting (Boston, 1993), the
Fourth World Congress of Biomaterials (Berlin, 1992),
the Fourth International Conference on Pharmaceutical
Technology (Paris, 1986) and the Annual Meetings of the
Italian (1990) and Danish (1986) Chemical Societies, the
Merck Distinguished Lectureship (Rutgers University,
2002), the Bayer Lectureship (University of Pittsburgh,
2000), the Minnetonka Lectureship (University of
Minnesota, 1988), the Warren McCabe Lectureship (North
Carolina State University, 1987) and others.
Peppas has
been elected a Founding Fellow of the American Institute
of Medical and Biological Engineering (1993), an
Inaugural Fellow of the Biomedical Engineering Society
(2005), a Fellow of the American Association of the
Advancement of Science (2000), a Fellow of the American
Physical Society (1997), a Fellow of the American
Institute of Chemical Engineers (1997), a Fellow of the
Society for Biomaterials (1994), a Fellow of the
American Association of Pharmaceutical Scientists (1993)
and an Honorary Member of the Italian Society of
Medicine and Natural Sciences (1996). In 1991 he was
named a Polymer Pioneer by Polymer News. In 2002 he was
named a Pioneer in Biomedical Engineering by the IEEE
Engineering in Medicine and Biology Society
Peppas has
supervised the theses of 73 Ph.D. students, including 33
current professors in other Universities, and another 67
students and 24 postdoctoral fellows and visiting
scientists. His former students include many industrial
leaders in chemical, pharmaceutical or medical
companies.
Peppas has
been active in teaching and counseling. For his
teaching, he has received the George Westinghouse (1992)
and the Western Electric Fund Teaching Award (1980) from
ASEE, the A.A. Potter Best Engineering Teacher Award of
Purdue University (in 1978, 1985, and 1994; only faculty
member to have achieved this honor three times), the
R.N. Shreve Chemical Engineering Teaching Award of
Purdue University (1978, 1980, 1982, 1985, 1988 and
1994); and the Most Outstanding ChE Faculty Member by the Engineering
Student Council of the University of Texas (2007).
For counseling he has received the 1992 AIChE Best
Counselor Award and the Marion B. Scott Award of Purdue
University (1999).
top |
